Search results for "Combinations"

showing 10 items of 204 documents

Budesonide/formoterol for the treatment of asthma.

2003

Budesonide/formoterol (Symbicort), AstraZeneca plc) is a novel treatment for asthma, combining an inhaled corticosteroid - budesonide, and a long-acting beta(2)-agonist - formoterol, in a single inhaler, the Turbuhaler. Randomised, clinical studies in patients with asthma have demonstrated that budesonide/formoterol is more effective than the inhaled corticosteroids, budesonide and fluticasone alone, and at least as effective as both monocomponents in separate inhalers. Results from clinical studies suggest a synergistic effect when both drugs are administered via one inhaler, although the mechanisms for this are not fully understood. Budesonide/formoterol has a rapid onset of effect, appar…

Budesonideimmune system diseasesFormoterol FumaratemedicineHumansPharmacology (medical)Anti-Asthmatic AgentsBudesonideChildAsthmaFluticasonePharmacologyCOPDbusiness.industryInhalerDrug SynergismGeneral Medicinerespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesDrug CombinationsBudesonide/formoterolEthanolaminesAnesthesiaFormoterol FumarateFormoterolbusinesshormones hormone substitutes and hormone antagonistscirculatory and respiratory physiologymedicine.drugExpert opinion on pharmacotherapy
researchProduct

Implanted neonatal human dermal fibroblasts influence the recruitment of endothelial cells in mice

2012

The vascularization of new tissue within a reasonable time is a crucial prerequisite for the success of different cell- and material-based strategies. Considering that angiogenesis is a multi-step process involving humoral and cellular regulatory components, only in vivo assays provide the adequate information about vessel formation and the recruitment of endothelial cells. The present study aimed to investigate if neonatal human dermal fibroblasts could influence in vivo neovascularization. Results obtained showed that fibroblasts were able to recruit endothelial cells to vascularize the implanted matrix, which was further colonized by murine functional blood vessels after one week. The ve…

CD31MalePathologymedicine.medical_specialtyAngiogenesisCell TransplantationBiomedical EngineeringCD34Medicine (miscellaneous)Neovascularization PhysiologicInflammationAntigens CD34BiologyNitric OxideRegenerative MedicineBiomaterialsNeovascularizationHemoglobinsMiceTissue engineeringMicroscopy Electron TransmissionIn vivoReportmedicineAnimalsHumansRegenerationSkinInflammationMatrigelNeovascularization PathologicTissue EngineeringEndothelial CellsGeneral MedicineFibroblastsMice Inbred C57BLPlatelet Endothelial Cell Adhesion Molecule-1Drug CombinationsPhenotypeProteoglycansCollagenLamininmedicine.symptom
researchProduct

Co-development of naive CD4+ cells towards T helper Type 1 or T helper type 2 cells induced by a combination of IL.-12 and IL-4

1997

Abstract Cytokines were found to play a key role in Th cell differentiation. Among them IL-12 was shown to be a potent differentiation factor for Th1 cells, whereas IL-4 is the only known cytokine that promotes the development of Th2 cells. Upon addition of comparable amounts of IL-4 and IL-12 to a primary culture of naive CD4 + T cells activated by immobilized anti-CD3 mAb, it was found that the Th1-inducing capacity of IL-12 is dominated by the Th2-promoting effect of IL-4. However, high amounts of IL-12 (10,000 U/ml) in combination with low amounts of IL-4 (100 U/ml) led to the development of a Th cell population that, upon rechallenge, showed a substantial secondary IFN-γ (Th1 cytokine)…

CD4-Positive T-LymphocytesMaleCellular differentiationmedicine.medical_treatmentImmunologyInterferon-gammaMiceInterleukin 21Th2 CellsmedicineAnimalsImmunology and AllergyCytotoxic T cellIL-2 receptorCells CulturedInterleukin 4Mice Inbred BALB CCD40biologyCell DifferentiationHematologyTh1 CellsInterleukin-12Molecular biologyDrug CombinationsCytokineMice Inbred DBAImmunologyMice Inbred CBAInterleukin 12biology.proteinFemaleInterleukin-4Immunobiology
researchProduct

Implantation of silicon dioxide-based nanocrystalline hydroxyapatite and pure phase beta-tricalciumphosphate bone substitute granules in caprine musc…

2012

Abstract Background Osteoinductive bone substitutes are defined by their ability to induce new bone formation even at heterotopic implantation sites. The present study was designed to analyze the potential osteoinductivity of two different bone substitute materials in caprine muscle tissue. Materials and methods One gram each of either a porous beta-tricalcium phosphate (β-TCP) or an hydroxyapatite/silicon dioxide (HA/SiO2)-based nanocrystalline bone substitute material was implanted in several muscle pouches of goats. The biomaterials were explanted at 29, 91 and 181 days after implantation. Conventional histology and special histochemical stains were performed to detect osteoblast precurs…

Calcium Phosphateslcsh:Specialties of internal medicineClinical Neurology610 MedizinBiocompatible MaterialsCerasorbHydroxyapatiteOsteogenesislcsh:RC581-951610 Medical sciencesAnimalsSolid-Phase Synthesis TechniquesDentistry(all)GoatsMusclesResearchNanocrystallineSilicon DioxideEctopic bone formationDrug CombinationsDurapatiteß-tricalciumphosphateOtorhinolaryngologyOsteoinductionBone SubstitutesModels AnimalNanoparticlesFemaleNanoBone
researchProduct

Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis

2012

The present study is designed to assess if exosomes released from Chronic Myelogenous Leukemia (CML) cells may modulate angiogenesis. We have isolated and characterized the exosomes generated from LAMA84 CML cells and demonstrated that addition of exosomes to human vascular endothelial cells (HUVEC) induces an increase of both ICAM-1 and VCAM-1 cell adhesion molecules and interleukin-8 expression. The stimulation of cell-cell adhesion molecules was paralleled by a dose-dependent increase of adhesion of CML cells to a HUVEC monolayer. We further showed that the treatment with exosomes from CML cells caused an increase in endothelial cell motility accompanied by a loss of VE-cadherin and β-ca…

Cancer ResearchAngiogenesisVascular Cell Adhesion Molecule-1BiologyExosomesArticleExosomes Chronic Myelogenous Leukemia Cells Endothelial cells Tumor MicroenvironmentMiceAntigens CDCell Movementhemic and lymphatic diseasesCell Line TumorLeukemia Myelogenous Chronic BCR-ABL PositivemedicineCell AdhesionHuman Umbilical Vein Endothelial CellsTumor MicroenvironmentAnimalsHumansCell adhesionbeta CateninMatrigelTumor microenvironmentNeovascularization PathologicCell adhesion moleculeInterleukin-8medicine.diseaseCadherinsIntercellular Adhesion Molecule-1MicrovesiclesCell biologyEndothelial stem cellDrug CombinationsOncologyGene Expression RegulationCancer researchProteoglycansCollagenLamininChronic myelogenous leukemia
researchProduct

GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer

2021

Pancreatic cancer is an aggressive malignancy with increasing incidence and poor prognosis due to its late diagnosis and intrinsic chemoresistance. Most pancreatic cancer patients present with locally advanced or metastatic disease characterized by inherent resistance to chemotherapy. These features pose a series of therapeutic challenges and new targets are urgently needed. Glycogen synthase kinase 3 beta (GSK3β) is a conserved serine/threonine kinase, which regulates key cellular processes including cell proliferation, DNA repair, cell cycle progression, signaling and metabolic pathways. GSK3β is implicated in non-malignant and malignant diseases including inflammation, neurodegenerative …

Cancer ResearchDNA repairDruggabilityDiseaseMalignancyPancreatic cancerHumansMedicinePharmacology (medical)GSK3BCell ProliferationPharmacologyGlycogen Synthase Kinase 3 betabusiness.industryKinaseGSK3βCancerTumor chromatin profilingOncogenesPancreatic cancermedicine.diseaseAnticancer drug combinationsPancreatic NeoplasmsInfectious DiseasesOncologyDrug Resistance NeoplasmCancer researchbusinessChemoresistanceDrug Resistance Updates
researchProduct

Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines – Identification of potential distinguishing markers

2021

As the frequency of cannabis-based therapy increases, the ability to distinguish intake of cannabis-based medicines from recreational cannabis use becomes desirable. Minor cannabinoids have been suggested to indicate recreational cannabis use in biological matrices but are unreliable when presumably also present in directly plantderived medicines. Thus, for therapeutics such as medical cannabis, Sativex® and Dronabinol, a more thorough investigation of cannabinoid profiles is required to identify possible distinguishing markers. In this study, 16 phytocannabinoids were quantified in samples of seized and medical cannabis, Sativex® and Dronabinol from two different manufacturers, using a val…

Cannabigerolmedicine.medical_treatmentMedical MarijuanaTetrahydrocannabivarinMass SpectrometryCannabicyclolPathology and Forensic MedicineCannabichromenechemistry.chemical_compoundmedicineCannabidiolHumansDronabinolPrincipal Component AnalysisbiologyTraditional medicineCannabinoidsbusiness.industrybiology.organism_classificationDrug CombinationschemistryCannabinolCannabinoidCannabisDronabinolbusinessLawChromatography Liquidmedicine.drugForensic Science International
researchProduct

''Investigating reduction of dimensionality during single-joint elbow movements: a case study on muscle synergies''

2013

Chiovetto, Enrico | Berret, Bastien | Delis, Ioannis | Panzeri, Stefano | Pozzo, Thierry; International audience; ''A long standing hypothesis in the neuroscience community is that the central nervous system (CNS) generates the muscle activities to accomplish movements by combining a relatively small number of stereotyped patterns of muscle activations, often referred to as" muscle synergies." Different definitions of synergies have been given in the literature. The most well-known are those of synchronous, time-varying and temporal muscle synergies. Each one of them is based on a different mathematical model used to factor some EMG array recordings collected during the execution of variety…

Computer scienceNeuroscience (miscellaneous)triphasic patternADJUSTMENTS''Variation (game tree)ORGANIZATIONTemporal musclelcsh:RC321-571NATURAL MOTOR BEHAVIORSnon-negative matrix factorizationACTIVATION03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineEMGEncoding (memory)muscle synergiesMATRIX FACTORIZATIONFeature (machine learning)Original Research ArticleSet (psychology)lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologydimensionality reductionARM MOVEMENTSELECTROMYOGRAPHIC PATTERNS0303 health sciencesbusiness.industryDimensionality reductionCOMBINATIONS[SCCO.NEUR]Cognitive science/Neuroscienceelbow rotationsNeurophysiologyADJUSTMENTSBODY POINTING MOVEMENTS[ SCCO.NEUR ] Cognitive science/Neuroscience''NATURAL MOTOR BEHAVIORSArtificial intelligencebusiness030217 neurology & neurosurgeryCognitive psychologyCurse of dimensionalityNeuroscienceTRIPHASIC EMG PATTERN
researchProduct

Antimicrobial activity and enterococcus faecalis biofilm formation on chlorhexidine varnishes.

2011

Objective: To evaluate, in vitro, the antimicrobial activity and biofilm formation of three chlorhexidine varnishes in four Enterococcus faecalis strains: E. faecalis ATCC 29212, E. faecalis EF-D1 (from failed endodontic treatment), E. faecalis 072 (cheese) and E. faecalis U-1765 (nosocomial infection), and one Enterococcus durans strain (failed endodontic treatment). Study Design: The direct contact test was used to study the antimicrobial activity. Bacterial suspensions were exposed for one hour to EC40, Cervitec (CE) and Cervitec Plus (CEP) varnishes. “Eradication” was defined as 100% bacterial kill. The formation of enterococci biofilms was tested on the surface of the varnishes after 2…

Contact testEnterococcus faecalisMicrobiologyEndodonticschemistry.chemical_compoundAnti-Infective AgentsmedicineEnterococcus faecalisChlorhexidine varnishGeneral DentistryThymolbiologyChlorhexidineChlorhexidineBiofilmbiochemical phenomena metabolism and nutrition:CIENCIAS MÉDICAS [UNESCO]biology.organism_classificationAntimicrobialEnterococcus duransThymolDrug CombinationsOtorhinolaryngologychemistryBiofilmsUNESCO::CIENCIAS MÉDICASSurgeryResearch-Articlemedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

Sealing ability of five different retrograde filling materials.

1996

The sealing ability of Amalgam, Harvard-Cement, Diaket, gold-leaf, and Ketac-Endo as retrofilling materials was investigated. Paper cones were fixed with Harvard-Cement in the instrumented roots of 100 extracted human incisors. Apicectomy was performed and a 2-mm-deep retrograde cavity was prepared. Teeth were assigned to five groups (n = 20); each group received a different filling material. Surfaces of the roots were isolated with nail polish. Teeth, were stored in 1% methylene blue dye for 72 h. Roots were sectioned, and the depth of dye penetration was evaluated through a stereomicroscope. Retrofills with Ketac-Endo showed significantly less leakage compared with amalgam. There was no s…

Dye penetrationZinc Phosphate CementMaterials scienceDentistryMandibleGold foilDental AmalgamApicectomyStatistics NonparametricRoot Canal Filling Materialsstomatognathic systemIncisorStereo microscopemedicineMaxillaHumansGeneral DentistryDental Leakagebusiness.industrySignificant differencetechnology industry and agricultureIncisorstomatognathic diseasesDrug Combinationsmedicine.anatomical_structureFilling materialsEvaluation Studies as TopicGlass Ionomer CementsRetrograde ObturationPolyvinylsZinc OxidebusinessBismuthZinc Phosphate CementJournal of endodontics
researchProduct